CF DRUG ORKAMBI CAN BE GIVEN TO CHILDREN FOLLOWING EU APPROVAL

The pharmaceutical firm making cystic fibrosis drug – Orkambi- says it’s got EU approval to treat children.

Manufacturer Vertex says it’ll now be suitable for use for those aged 6 to 11.

It’s already licensed for patients 12 and over.

Earlier this year the HSE agreed to make Orkambi available to Irish patients after major price negotiations with the pharma industry.

Advertisement

More News